NDC 12496-0300 – Sublocade

Buprenorphine 300 mg/1 · Solution · Subcutaneous

Human Prescription Drug DEA schedule CIII

Product NDC12496-0300

Product details

Brand name
Sublocade
Generic name
Buprenorphine
Labeler
Indivior Inc.
Dosage form
Solution
Route
Subcutaneous
Marketing category
NDA · NDA209819
Marketed since
February 26, 2018
Listing expires
December 31, 2027
Pharmacologic class
Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Sublocade →

Package NDC codes (1)

Package NDCDescriptionSince
12496-0300-11 POUCH in 1 CARTON (12496-0300-1) / 1 SYRINGE in 1 POUCH (12496-0300-2) / 1 SOLUTION in 1 SYRINGE (12496-0300-5)Feb 26, 2018

Other Sublocade products